Wealth Preservation Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,543
Closed -$154K 199
2026
Q1
$154K Buy
2,543
+147
+6% +$8.57K 0.13% 78
2025
Q4
$129K Buy
2,396
+12
+0.5% +$577 0.07% 117
2025
Q3
$108K Sell
2,384
-33
-1% -$1.54K 0.06% 128
2025
Q2
$112K Hold
2,417
0.07% 124
2025
Q1
$147K Buy
+2,417
New +$141K 0.11% 96

Other funds holding BMY

Wealth Preservation Advisors's BMY Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 2,543 shares — an estimated $154K sold.

Wealth Preservation Advisors first reported a position in BMY in Q1 2025 and held it in 5 quarters. The position peaked at $154K in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 2,543 Bristol-Myers Squibb shares in Q2 2026, an estimated $154K.
  • Wealth Preservation Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 5 quarters.
  • Wealth Preservation Advisors's Bristol-Myers Squibb position peaked at $154K in Q1 2026.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.